Home › Funds › B Group, Inc. › IOVA

B Group, Inc. position in IOVA

IOVANCE BIOTHERAPEUTICS · Health Care

B Group, Inc. reported holding 1,500,000 shares of IOVA (IOVANCE BIOTHERAPEUTICS) in its Q2 2026 13F filing — a position valued at US$6.2M, representing 2.93% of its reported portfolio and ranking #12 among its reported holdings. B Group, Inc. has disclosed IOVA holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)1.50M sh
Reported value held$6.24M
Portfolio Weight2.93%
First reportedQ4 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How B Group, Inc.'s IOVA position evolved

B Group, Inc. first disclosed a stake in IOVA in Q4 2024 at 992,000 shares (US$7.3M). Across 7 filings, B Group, Inc. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2026) shows 1,500,000 shares valued at US$6.2M. Notable position changes include a 51% increase in Q1 2025 (shares fell 48% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 992.00K $7.34M New
Q1 2025 1.50M $5.00M Add
Q2 2025 1.50M $2.58M Hold
Q3 2025 1.50M $3.25M Hold
Q4 2025 1.50M $4.09M Hold
Q1 2026 1.50M $5.26M Hold
Q2 2026 1.50M $6.24M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IOVA and 13F data

IOVA (IOVANCE BIOTHERAPEUTICS) is a Health Care company. 28 other funds we track also report a position in IOVA — the largest reported positions include MHR FUND MANAGEMENT LLC (US$120.5M), Palo Alto Investors LP (US$22.0M), Mirador Capital Partners LP (US$16.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IOVA

All IOVA fund holders →

FAQ

How long has B Group, Inc. held IOVA?

B Group, Inc. has disclosed IOVA holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

What is B Group, Inc.'s current position in IOVA?

As of Q2 2026, B Group, Inc. holds 1.50M shares of IOVA (IOVANCE BIOTHERAPEUTICS), valued at $6.24M, representing 2.93% of its reported portfolio and ranking #12.

Has B Group, Inc. been buying or selling IOVA?

In the latest 13F filing (Q2 2026), B Group, Inc. held unchanged its position in IOVA.

Which other funds hold IOVA?

Other major institutional holders of IOVA include MHR FUND MANAGEMENT LLC, Palo Alto Investors LP, Mirador Capital Partners LP, among 28 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.